本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kura Oncology, Inc

8.82
+0.33003.89%
盘后8.890.0709+0.80%19:03 EDT
成交量:145.65万
成交额:1,269.11万
市值:7.79亿
市盈率:-2.78
高:8.93
开:8.47
低:8.25
收:8.49
52周最高:12.49
52周最低:5.45
股本:8,832.98万
流通股本:6,398.56万
量比:0.79
换手率:2.28%
股息:- -
股息率:- -
每股收益(TTM):-3.1784
每股收益(LYR):-3.1784
净资产收益率:-94.82%
总资产收益率:-25.33%
市净率:4.47
市盈率(LYR):-2.78

数据加载中...

2025/03/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/05

重要事件披露

Form 8-K - Current report
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/15

重要事件披露

Form 8-K - Current report
2025/01/07

重要事件披露

Form 8-K - Current report
2024/12/20

重要事件披露

Form 8-K - Current report
2024/12/05

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/20

重要事件披露

Form 8-K - Current report
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

重要事件披露

Form 8-K - Current report